| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 02/06/2008 | EP1883407A1 Compositions and methods for treatment for neoplasms |
| 02/06/2008 | CN101119974A Amide derivatives as PPAR activators |
| 02/06/2008 | CN101119951A Modulator |
| 02/06/2008 | CN101117332A Preparation method of 2-chloronicotinic acid |
| 02/06/2008 | CN101117331A Method for preparing 3-pyridine acetic acid hydrochloride |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 02/05/2008 | US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide |
| 02/05/2008 | US7326732 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders |
| 02/05/2008 | US7326731 Muscarinic agonists |
| 02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
| 02/05/2008 | US7326278 Advanced contaminate treatment system |
| 02/05/2008 | CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 02/05/2008 | CA2284977C 3,3-disubstituted propylamines, their use and preparation |
| 01/31/2008 | WO2008013334A1 Deformylase inhibitor, process for the preparation thereof, and composition comprising the same |
| 01/31/2008 | WO2008012532A2 : pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase |
| 01/31/2008 | WO2007120574A3 Diaryl substituted alkanes |
| 01/31/2008 | WO2007109459A3 Pyridines and pyridine n-oxides as modulators of thrombin |
| 01/31/2008 | US20080027230 reacting an onium chloride with an acid resulting in formation of hydrochloric acid, formed hydrochloric acid is removed by azeotropic distillation by coordination to 1,4-dioxane which forms an azeotropic mixture with water; |
| 01/31/2008 | US20080027229 Compounds for the treatment of metabolic disorders |
| 01/31/2008 | US20080027228 Substituted thioacetamides |
| 01/31/2008 | US20080027224 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 01/31/2008 | US20080027109 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 01/31/2008 | US20080027104 Novel Crystalline Forms 2 |
| 01/31/2008 | US20080027103 Novel Crystalline Forms 1 |
| 01/31/2008 | US20080027098 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPARalpha activation |
| 01/31/2008 | US20080027097 Pharmaceutical drug candidates and methods for preparation thereof |
| 01/31/2008 | US20080027096 Novel Pharmaceutical Compositions |
| 01/31/2008 | US20080027077 Novel biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/31/2008 | US20080027066 Arylpiperazinyl Compounds |
| 01/31/2008 | US20080027061 omega-Carboxy Aryl Substituted Diphenyl Ureas As p38 Kinase Inhibitors |
| 01/31/2008 | US20080027060 Dipeptide nitriles |
| 01/31/2008 | US20080027036 S1P receptor modulating compounds and use thereof |
| 01/31/2008 | US20080025915 Technetium-And Rhenium-Bis (Heteroaryl) Complexes, And Methods Of Use Thereof |
| 01/31/2008 | CA2658887A1 Fatty acid amide hydrolase inhibitors |
| 01/31/2008 | CA2658624A1 Pyridazine and pyrrole compounds, processes for obtaining them and applications thereof |
| 01/31/2008 | CA2657247A1 Compounds which modulate the cb2 receptor |
| 01/30/2008 | EP1882687A1 Heterocyclic compounds useful as vanilloid receptor antagonists and pharmaceutical compositions containing the same |
| 01/30/2008 | EP1881958A1 Diacylglycerol acyltransferase inhibitors |
| 01/30/2008 | CN101115748A Acetamide compounds as fungicides |
| 01/30/2008 | CN101115722A Compounds and compositions as modulators of steroidal receptors and calcium channel activities |
| 01/30/2008 | CN101115721A Indenyl derivatives and use thereof for the treatment of neurological disorders |
| 01/30/2008 | CN101115713A HIV protease inhibitors |
| 01/30/2008 | CN101115710A Diamine calcium channel blockers |
| 01/30/2008 | CN101113138A Method for synthesizing aryl radical nitrile derivant under catalysis of cyclopalladated ferrocenylimines complex |
| 01/30/2008 | CN100364977C Alkylviolagen iodine salt preparation method |
| 01/29/2008 | US7323608 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2008 | US7323594 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 01/29/2008 | US7323563 Hydroxamic acid derivatives as antibacterials |
| 01/29/2008 | US7323496 Compounds for treatment of inflammation, diabetes and related disorders |
| 01/29/2008 | US7323448 Antibacterial agents |
| 01/29/2008 | CA2294347C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase |
| 01/29/2008 | CA2220999C Process for the hydrogenation of imines |
| 01/29/2008 | CA2142998C N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors |
| 01/29/2008 | CA2136120C Treatment of incontinence |
| 01/24/2008 | WO2008011117A2 Antiviral protease inhibitors |
| 01/24/2008 | WO2008010796A1 Process for preparing pyridine-2-carboxamides and intermediates therefor |
| 01/24/2008 | WO2008010455A1 METHOD FOR PRODUCING β-DIARYL ELECTRON-WITHDRAWING GROUP SUBSTITUTED COMPOUND |
| 01/24/2008 | WO2008010235A2 An improved process for the preparation of donepezil |
| 01/24/2008 | WO2008009360A2 N'-cyano-n-alkyl halide imide amide derivatives |
| 01/24/2008 | WO2007137103A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 01/24/2008 | WO2007135562A3 Hydroxyphenyl derivatives and biological applications thereof |
| 01/24/2008 | WO2007126957A3 New compounds |
| 01/24/2008 | WO2007103719A3 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
| 01/24/2008 | WO2006135733A3 Modulation of peripheral clocks in adipose tissue |
| 01/24/2008 | US20080021180 Chromium catalysts active in olefin polymerization |
| 01/24/2008 | US20080021175 Compositions and methods for polymer composites |
| 01/24/2008 | US20080021109 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/24/2008 | US20080021070 Pyridine derivatives, preparation and therapeutic application thereof |
| 01/24/2008 | US20080021012 3-[4-{6-Substituted Alkanoyl Pyridin-3-Yl}-3-Phenyl]-5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones As Antibacterial Agents |
| 01/24/2008 | DE102007032612A1 Polymorphe Formen von Flupirtinmaleat Polymorphic forms of flupirtine maleate |
| 01/24/2008 | DE102006033572A1 N'-Cyano-N-halogenalkyl-imidamid Derivate N'-cyano-N-haloalkyl-imide amide derivatives |
| 01/24/2008 | DE102006031143A1 Fluortenside Fluorosurfactants |
| 01/24/2008 | CA2658535A1 N'-cyano-n-halogenalkylimidamide derivatives |
| 01/24/2008 | CA2657936A1 Antiviral protease inhibitors |
| 01/23/2008 | EP1879895A1 Enzyme inhibitors |
| 01/23/2008 | EP1879881A2 Inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 01/23/2008 | EP1879864A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls |
| 01/23/2008 | EP1879564A2 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 01/23/2008 | EP1879548A2 Process for coloring keratin fibers comprising metal complexes |
| 01/23/2008 | EP1633714B1 2-amino-pyridine derivatives as beta-2 adrenoreceptor agonists |
| 01/23/2008 | EP1633354B1 N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes |
| 01/23/2008 | EP1567498B1 Mandelic acid derivatives |
| 01/23/2008 | EP1556354B1 Therapeutic piperazine derivates useful for treating pain |
| 01/23/2008 | EP1432313B1 N-thio-nicotinamide derivatives and related compounds for use as pesticides |
| 01/23/2008 | EP1427721B1 Method for synthesis of 5-(3-pyridylmethylene)-imidazolidine-2,4-dione |
| 01/23/2008 | EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 01/23/2008 | CN101111480A 取代的吡啶酮衍生物 Substituted pyridone derivative |
| 01/23/2008 | CN101111479A Pyridones used as inhibitors of kinases |
| 01/23/2008 | CN101111267A Stabilized polymeric thiol reagents |
| 01/23/2008 | CN101108861A Salts comprising cyanoborate anions |
| 01/23/2008 | CN101108827A Method for manufacturing acetic acid type ionic liquid |
| 01/23/2008 | CN101108824A Method for synthesizing 2- chlorine -3- cyanogen radical pyridine with 3- cyanogen radical pyridine |
| 01/23/2008 | CN101108823A Method for preparing 3-picoline amido derivant |
| 01/23/2008 | CN101108822A Method of manufacturing glyphosate cogeneration paraquat |
| 01/23/2008 | CN101108821A Method of manufacturing 2-picoline |
| 01/23/2008 | CN101108759A Salts comprising cyanoborate anions |
| 01/23/2008 | CN101108366A Method for manufacturing catalyst used for synthesizing 2-picoline |
| 01/23/2008 | CN100363362C Thiazole derivatives as NPY receptor antagonists |